MARZOLA, Erika
 Distribuzione geografica
Continente #
NA - Nord America 4.240
AS - Asia 1.923
EU - Europa 1.498
SA - Sud America 311
AF - Africa 48
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.026
Nazione #
US - Stati Uniti d'America 4.151
SG - Singapore 841
CN - Cina 537
IT - Italia 391
DE - Germania 253
BR - Brasile 241
HK - Hong Kong 173
GB - Regno Unito 159
PL - Polonia 159
UA - Ucraina 158
TR - Turchia 107
VN - Vietnam 107
FI - Finlandia 101
SE - Svezia 60
CA - Canada 53
RU - Federazione Russa 51
FR - Francia 45
ID - Indonesia 42
MX - Messico 30
ZA - Sudafrica 28
AR - Argentina 27
BE - Belgio 27
NL - Olanda 25
JP - Giappone 24
IN - India 23
CO - Colombia 16
LT - Lituania 15
BD - Bangladesh 14
ES - Italia 13
IE - Irlanda 11
AT - Austria 10
IR - Iran 10
EC - Ecuador 7
IQ - Iraq 7
PK - Pakistan 7
UY - Uruguay 7
IL - Israele 6
CZ - Repubblica Ceca 5
MA - Marocco 4
PE - Perù 4
RO - Romania 4
SA - Arabia Saudita 4
VE - Venezuela 4
BG - Bulgaria 3
DZ - Algeria 3
KZ - Kazakistan 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
AO - Angola 2
AU - Australia 2
CL - Cile 2
KE - Kenya 2
KR - Corea 2
MY - Malesia 2
PA - Panama 2
PT - Portogallo 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
JO - Giordania 1
LV - Lettonia 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 8.026
Città #
Ashburn 501
Singapore 500
Fairfield 423
Woodbridge 404
Ann Arbor 238
Houston 220
Beijing 213
Santa Clara 193
Seattle 186
Hong Kong 169
Jacksonville 168
Chandler 166
Ferrara 161
Warsaw 154
Cambridge 149
Wilmington 147
New York 110
Munich 89
Los Angeles 74
Dallas 73
Milan 63
Izmir 59
Princeton 52
Dearborn 47
Nanjing 47
Addison 44
Ho Chi Minh City 43
Helsinki 39
Shanghai 39
San Diego 36
Jakarta 33
Turku 31
Boardman 30
Brussels 25
London 25
São Paulo 25
Bologna 23
The Dalles 23
Tokyo 23
Mexico City 20
Montreal 20
Falkenstein 19
Frankfurt am Main 19
Brooklyn 18
Johannesburg 18
Atlanta 17
Chicago 17
Auburn Hills 16
Redwood City 16
Hefei 15
Nanchang 15
Toronto 14
Boston 12
Bremen 12
Buffalo 12
Denver 12
Hanoi 12
San Mateo 12
Ferrara di Monte Baldo 11
Manchester 11
San Francisco 11
Shenyang 11
Tianjin 11
Changsha 10
Dublin 10
Hebei 10
Mountain View 10
Orem 10
Phoenix 10
Stockholm 10
Istanbul 9
Medellín 9
Moscow 9
Padova 9
Poplar 9
Turin 9
Jinan 8
Norwalk 8
Philadelphia 8
Washington 8
Augusta 7
Bexley 7
Columbus 7
Jiaxing 7
Montevideo 7
Ningbo 7
Tappahannock 7
Charlotte 6
Chennai 6
Curitiba 6
Florence 6
Guangzhou 6
Nuremberg 6
Zhengzhou 6
Biên Hòa 5
Dong Ket 5
Falls Church 5
Kunming 5
Lima 5
Ninh Bình 5
Totale 5.673
Nome #
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 252
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 243
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 241
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 219
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 206
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 206
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 204
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 199
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 198
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 198
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 196
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 191
Physicochemical stability of cabazitaxel and docetaxel solutions 190
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 189
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 189
Pharmacological characterization of tachykinin tetrabranched derivatives 188
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 177
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 169
Structure-activity study at positions 3 and 4 of human neuropeptide S. 168
Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans 168
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 164
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 164
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 161
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 155
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 154
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 152
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 152
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 151
Structure-activity relationship study on human urotensin II 148
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 146
Synthesis and antimicrobial activity of dermaseptin S1 analogues 144
Thermodynamic and spectroscopic investigation on the role of Met residues in CuII binding to the non-octarepeat site of the human prion protein 142
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 141
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 139
Synthesis of 2,6-Dimethyltyrosine-Like Amino Acids through Pinacolinamide-Enabled C-H Dimethylation of 4-Dibenzylamino Phenylalanine 133
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 129
Role of 2′,6′-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds 126
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 125
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 123
Novel Mixed NOP/Opioid Receptor Peptide Agonists 116
How terminal protection affects the chemical and biological properties of the antimicrobial calcitermin 115
Impact of C- and N-terminal protection on the stability, metal chelation and antimicrobial properties of calcitermin 104
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 103
CCR4+ CD8+ T cells clonally expand to differentiated effectors in murine psoriasis and in human psoriatic arthritis 96
null 94
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 92
The N-terminal domain of Helicobacter pylori's Hpn protein: The role of multiple histidine residues 90
METRICS project: Synthesis of Manganese Complexes as potential PET/MRI Agents 90
Manganese complexes for multimodal PET/MRI imaging: progress of METRICS project 83
Synthesis and characterization of manganese dithiocarbamate complexes: New evidence of dioxygen activation 78
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays 72
Positively charged residues play a significant role in enhancing the antibacterial activity of calcitermin 67
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid 65
Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity 53
Production and Characterization of Semi-Solid Formulations for the Delivery of the Cosmetic Peptide Palmitoyl-GHK 42
null 42
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 19
Totale 8.161
Categoria #
all - tutte 39.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 525
Totale 40.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021472 0 0 0 0 0 67 79 83 36 71 95 41
2021/2022595 28 53 47 42 33 14 35 37 37 51 55 163
2022/2023485 58 31 26 54 62 50 55 50 46 2 29 22
2023/2024396 31 41 26 10 16 90 17 46 10 11 18 80
2024/20251.453 35 29 146 62 175 142 28 71 255 129 188 193
2025/20262.286 460 158 329 481 624 234 0 0 0 0 0 0
Totale 8.161